GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
91.29
+1.01 (1.11%)
Aug 27, 2026, 9:56 AM EDT - Market open
GeneDx Holdings Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 454.43 | 427.54 | 305.45 | 202.57 | 234.69 | 212.2 |
Revenue Growth | 25.42% | 39.97% | 50.79% | -13.69% | 10.60% | 18.33% |
Gross Profit Gross Profit Growth | 315.3 | 298.18 | 194.45 | 90.15 | -26.75 | -16.6 |
Operating Income Operating Income Growth | -59.67 | -11.67 | -23.16 | -170.06 | -457.51 | -446.15 |
Net Income Net Income Growth | -106.36 | -21.02 | -52.29 | -175.77 | -548.98 | -245.39 |
Earnings Per Share EPS Growth | -3.64 | -0.73 | -1.94 | -7.23 | -53.63 | -74.93 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Fabric Genomics and Legacy Sema4 Fabric Genomics and Legacy Sema4 Growth | 31.34 | 4.45 | - | - | - | - |
Gene Dx Gene Dx Growth | - | 423.09 | 302.29 | 194.38 | 122.23 | - |
Legacy Sema4 Legacy Sema4 Growth | - | - | 3.16 | 8.19 | 112.46 | 212.2 |
Total Total Growth | 454.43 | 427.54 | 305.45 | 202.57 | 234.69 | 212.2 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 132.55 | 171.28 | 141.19 | 130.15 | 123.93 | 400.57 |
Total Debt Total Debt Growth | 167.4 | 113.17 | 117.38 | 119.27 | 77.13 | 11 |
Net Cash (Debt) Net Cash Growth | -34.85 | 58.11 | 23.81 | 10.88 | 46.8 | 389.57 |
Net Cash Growth | - | 144.11% | 118.91% | -76.76% | -87.99% | 517.31% |
Net Cash Per Share Net Cash Per Share Growth | -1.19 | 2.03 | 0.89 | 0.45 | 4.57 | 118.95 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -48.71 | 33.28 | -28.5 | -180.15 | -319.16 | -190.43 |
Capital Expenditures CapEx Growth | -27.09 | -19.02 | -5.49 | -5.25 | -7.16 | -9.4 |
Free Cash Flow Free Cash Flow Growth | -75.8 | 14.26 | -33.99 | -185.4 | -326.31 | -199.83 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 69.38% | 69.74% | 63.66% | 44.50% | -11.40% | -7.82% |
Operating Margin | -13.13% | -2.73% | -7.58% | -83.95% | -194.94% | -210.25% |
Pretax Margin | -23.39% | -4.94% | -17.23% | -87.23% | -254.81% | -115.64% |
Profit Margin | -23.41% | -4.92% | -17.12% | -86.77% | -233.91% | -115.64% |
FCF Margin | -16.68% | 3.34% | -11.13% | -91.52% | -139.04% | -94.17% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | 132.42 | 250.14 | 190.96 | - | - | - |
P/FCF Ratio | - | 263.59 | - | - | - | - |
PS Ratio | 5.93 | 8.79 | 6.91 | 0.35 | 0.44 | 5.07 |